Abstract: Does hepatitis D in HBV/ HIV co-infected patients affect liver function? | J. Kozlowska #1

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Abstract: Antioxidant response in patients with chronic hepatitis B or C. | K. Wójcik-Cichy #2

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

State of the Art Treatment of Hepatitis B | Maria Buti, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Abstract: Chronic Hepatitis C Treatment In Patients Coinfected With HCV/HIV | S. Fedorchenko #4

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Abstract: Toll-like receptor 4 polymorphism influence on the clinical course of chronic hepatitis C in HIV-infected patients | T. Kyrychenko #5

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Acute Hepatitis C Infection | Christoph Boesecke, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Abstract: Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1. | S. Mauss #6

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Abstract: Endothelial dysfunction and its influence on the development of subclinical atherosclerosis in HIV/HCV positive patients | K. Barska #10

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Abstract: Evaluation of early cerebral alterations in the course of HIV and HCV infection using perfusion MR imaging: is the hepatitis C virus more dangerous for the brain? | J. Bladowska #8

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Poland | Milosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

AbbVie

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Ukraine | Larisa Moroz, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Romania | Adrian Streinu Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Baltic Countries | Saulius Caplinskas, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Czech and Slovak Republics | Viktor Aster, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Turkey | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of End-stage Liver Disease | Massimo Puoti, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

State of the Art Treatment of HCV | Sanjay Bhagani, BSc FRCP

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe | Mojca Maticic, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Natural History of HCV Infection | Krzysztof Simon, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of Drug Drug Interactions | David Back, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Inhibition of HIV Integrase: Virology and Resistance | Charles Boucher, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Clinically Relevant Drug Interactions | Saye Khoo

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Integrase Inhibitors: Clinical Considerations | Jonathan Schapiro, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015